Wird geladen...
Drug Development for Alzheimer's Disease: Where Are We Now and Where Are We Headed?
OBJECTIVE: To provide a brief survey of the clinical development of Alzheimer's disease (AD) pharmacotherapy. METHODS: The search process included PubMed, www.ClinicalTrials.gov, the International Conference on Alzheimer's Disease 2008 (ICAD), and pharmaceutical company and AD advocacy Web...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2009
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2948028/ https://ncbi.nlm.nih.gov/pubmed/19616185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjopharm.2009.06.003 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|